Immunoprecipitation and Western blot results showed that both phosphorylation of 3βHSD1 and metabolic flux from DHEA to AD were reduced by inhibiting BMX with zanubrutinib (Figure 6C). This evidence concerns the gene BMX and Alzheimer disease.